Second-line treatment for immune thrombocytopenia (ITP) is not well reported for patients treated in real-world clinical settings.

The purpose of this study was to compare outcomes of four second-line treatments for ITP.

Included adult patients had at least two medical records containing ITP diagnoses and second-line eltrombopag,…[Read more]

For patients, the reactions to the tools were more positive. Patients valued written information and a signed agreement to delay the test. However, patients expressed that a strong desire for diagnostic imaging would likely over-ride any effect of written advice to delay the test. The term ‘false alarm’ to describe overdiagnosis was poorly…[Read more]

SLE/CYC+ women had a greater prevalence of AMH <1.0 ng/mL compared with women without SLE (prevalence ratio (PR) 2.90, 95% CI 1.29 to 6.51). SLE/CYC- women were also slightly more likely to have AMH <1.0 ng/mL (PR 1.62, 95% CI 0.93 to 2.82) than comparison women. Results were similar when considering AMH <25th percentile by age of comparison women…[Read more]